This report provides exclusive insights into the COVID-19 impact on the RNAi Technology Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the RNAi Technology Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of RNAi Technology Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
report published by Infinium Global Research on RNAi technology market provides
in-depth analysis of segments and sub-segments in the global as well as
regional RNAi technology market. The study also highlights the impact of
drivers, restraints, and macro indicators on the global and regional RNAi
technology market over the short term as well as long term. The report is a
comprehensive presentation of trends, forecast and dollar values of global RNAi
technology market. According to the report, the global RNAi technology market
is projected to grow at a CAGR of 19.8% over the forecast period of 2019-2025.
interference (RNAi) is a biochemical process in which RNA molecules inhibit
gene expression or translation, by neutralizing targeted mRNA molecules. In
RNAi technology, double-stranded RNA silences the gene expression. This is by
inhibition of the translation process or by the degradation of mRNA. RNAi
facilitates cellular defense from infections occurred by RNA viruses such as
influenza virus and rhabdovirus. Transposons and viruses are the targets of
RNAi technology. RNAi technology helps in regulating the development and
maintenance of the genome. RNAi technology is used to extract cells that are
resistant to infectious organisms. RNAi technology hits on the protein which
causes the spread of the virus. There are in-vitro applications of RNAi
technology in mammals for various diseases. RNAi technology is estimated to be
an important factor in evolution due to its essential role in epigenetics.
extensive use of RNAi technology in the treatment of viral diseases,
neurodegenerative diseases and oncology, is driving the growth of RNAi
technology market. Cancer, HIV, Parkinson’s disease, Respiratory syncytial
virus, and Hepatitis are diseases treated by RNAi technology. According to WHO,
in 2017, globally 940000 people died of HIV. Countries have a commitment to the
eradication of diseases, this heading to the growth of RNAi technology in the
market. Furthermore, investments from major pharmaceutical companies in the
biotechnology industry are also driving the growth of the same. However, high
cost in the application of RNAi technology in the production of therapeutics
and drug discoveries is likely to hamper the growth of this market. The increase
in growth of RNAi technology in therapeutics, drug discovery, development and
agriculture can provide growth opportunities to the RNAi technology market.
the geographies, North America dominates the market by holding a major share in
the market of RNAi technology. Increasing instances of viral diseases and
cancer are stimulating the growth of the market. Moreover, the growth of
biotechnology industries has also increased in the past few years heading to
the growth of the market in North America. Moreover, Europe holds the second largest share in the growth of the
RNAi technology market. The Asia Pacific is the fastest growing region as there
is rising disposable income in this region. Growing technological advances in
this region boost the growth of RNAi technology market.
The report on
global RNAi technology market covers segments such as therapeutics. On the
basis of therapeutics, the sub-markets include oncology, hepatitis b and c, neurological
disorders, autoimmune hepatitis, and others therapeutics.
provides profiles of the companies in the market such as Thermo Fisher
Scientific, Silence Therapeutics, Merck & Co., Inc., Ionis Pharmaceuticals,
Quark Pharmaceuticals, Dicerna Pharmaceuticals, Arcturus Therapeutics Ltd., and
Alnylam Pharmaceuticals Inc.
provides deep insights into the demand forecasts, market trends, and micro and
macro indicators. In addition, this report provides insights into the factors
that are driving and restraining the growth in this market. Moreover, The
IGR-Growth Matrix analysis given in the report brings an insight into the
investment areas that existing or new market players can consider. The report
provides insights into the market using analytical tools such as Porter's five
forces analysis and DRO analysis of RNAi technology market. Moreover, the study
highlights current market trends and provides forecast from 2019-2025. We also
have highlighted future trends in the market that will affect the demand during
the forecast period. Moreover, the competitive analysis given in each regional
market brings an insight into the market share of the leading players.